Navigation Links
Encision Pursues Transfer of Quotation to OTC Bulletin Board
Date:10/14/2008

BOULDER, Colo., Oct. 14 /PRNewswire-FirstCall/ -- Encision Inc. (Pink Sheets: ECIA) ("Encision," or the "Company"), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, announced today that the Company is in the process of transferring the quotation of its common stock to the OTC Bulletin Board ("OTCBB") and that it has identified a sponsoring market maker who will make an application to quote the common stock of Encision on the OTCBB. The Company's directors, executives and 10% shareholders have filed information with the market maker.

Trading of the Company's common stock on the OTCBB, which is maintained by the Financial Industry Regulatory Authority ("FINRA"), is subject to a market maker's filing of a Form 211 with, and the clearance of such Form 211 by, FINRA. We expect that the market maker will file a Form 211 with FINRA to seek clearance to quote the Company's common stock on the OTCBB within ten days. The Company's common stock is currently quoted on the Pink Sheets, an electronic quotation service for securities traded over-the-counter, and will continue to be quoted on the Pink Sheets.

Jack Serino, President and CEO of Encision, said, "The Company is aggressively pursuing quotation of its common stock on the OTCBB. Until the market maker files the Form 211 and FINRA clears the Company's common stock for quotation on the OTCBB we will, in the interim, trade on the Pink Sheets. The Company will endeavor to operate in compliance with the reporting requirements for the OTCBB, which will include continuing to file with the SEC and all other applicable regulatory authorities."

There can be no assurance that the Company's common stock will be granted eligibility to be quoted on the OTCBB. Quotation on the OTCBB requires companies to be current in their filings with the SEC. The Company believes that it is current with its filings with the SEC and all other
'/>"/>

SOURCE Encision Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Encision Reports First Fiscal Quarter Results
2. Encision Reports Fourth Quarter and Fiscal Year 2008 Results
3. Encision Moves Power and Safety to Surgeons Fingertips
4. Encision Supports National Patient Safety Awareness Week
5. Encision Reports Third Fiscal Quarter Results
6. American Stock Exchange Accepts Encisions Plan to Regain Compliance
7. Gene-Transfer Proves Safe for Vision Problem
8. AUA 2008: Maxi-K gene transfer may prove to be safe and effective erectile dysfunction treatment
9. California Nursing Home, Homecare Workers Vote Overwhelmingly to Preempt Forced Transfer
10. Barrier Technology Provides New Weapon in MRSA War: Surface Care Products Prevent Growth and Transfer of Bacteria
11. Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in Worlds Poorest Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Albany, NY (PRWEB) June 19, 2013 ... Global Industry Size, Market Share, Trends, Analysis and Forecast, ... worth USD 6.2 billion in the year 2011 and ... growing at a CAGR of 9.7% from 2011 to ... overall endoscopes market, contributing about USD 2,201 million for ...
(Date:6/19/2013)... treating stroke victims has been "time equals brain." That,s because ... a drug that dissolves the stroke-causing blood clot can make ... or lost. , But specific information has been ... drug known as a tissue plasminogen activator, or tPA ... most common type of stroke. , Now, a ...
(Date:6/19/2013)... MAYWOOD, Il. A Loyola University Chicago Niehoff School ... grant to study whether Vitamin D can improve mood ... study also will examine whether vitamin D supplementation can ... their diabetes. The grant is from the National Institute ... , Principal investigator Sue M. Penckofer, PhD, RN and ...
(Date:6/19/2013)... AquaPrint Solutions in Thomson, IL is proud to present ... Harley Davidson motorcycle gas tank. A couple of weeks ago, ... of taking a split tank motorcycle that had been roughed ... a work of art. , In October of 2012, ... that had been dipped in a water transfer printer with ...
(Date:6/19/2013)... 2013 Fit Body Boot Camp in ... a charity boot camp in order to support Orlando resident, ... boot camp franchise hosted the Brent Can Breathe fundraiser ... 75 boot camp participants and collected over $700. , Officially ... the second fundraiser held for Orlando local Brent Snyder, 24, ...
Breaking Medicine News(10 mins):Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:Loyola receives $1.5 million grant to study vitamin D for diabetes and depression 2Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2
... 1 issue of the journal Sleep indicates that ... remain vigilant and attentive deteriorated significantly after losing less than ... study suggests that even moderate reductions in sleep duration can ... the academic performance of children with ADHD. Results of ...
... This release is also available in Chinese on ... Despite the absence of Medicare coverage, hospital use of computed ... the rise, according to a study in the March issue of ... www.jacr.org ). Colorectal cancer is the second leading cause of ...
... dissection, the current standard surgical treatment for localized non-small ... stage cases , according to a study published in the ... (JTO), the official journal of the International Association for the ... is very low in early-stage cancers with a maximum standard ...
... adhesive patches is at the center of an agreement ... arm of Italian pharmaceutical leader Zambon Co., SpA, to ... ways to deliver oral medications directly to a targeted ... sponsored research agreement between Zcube and UCSF, but is ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... fears soaring as quickly as a child,s rapidly rising temperature. ... Pediatrics (AAP) attempts to allay those fears by reminding parents ... against illness, and that lowering a fever may actually prolong ...
... , MONDAY, Feb. 28 (HealthDay News) -- Many American women ... treatment was tied to higher breast cancer risk. A sharp ... after. However, a new study suggests that the 2002-2003 ... continue through 2007. The data suggests that the drop ...
Cached Medicine News:Health News:Moderate sleep loss impairs vigilance and sustained attention in children with ADHD 2Health News:Moderate sleep loss impairs vigilance and sustained attention in children with ADHD 3Health News:Hospital use of virtual colonoscopy is on the rise, study suggests 2Health News:Lymph node dissection is not essential in small screen-detected lung cancers, new research shows 2Health News:UCSF collaborates with Zcube to develop new ways to deliver drugs 2Health News:Kids' Fevers May Not Always Need Treatment 2Health News:Kids' Fevers May Not Always Need Treatment 3Health News:Drop in Breast Cancer Among White Women May Have Stalled 2
(Date:6/19/2013)... Today MedeAnalytics, a leading provider of ... its Employer Group and Individual Business Analytics ... their employer groups an intuitive and insightful view ... drug claims, network utilization, and overall financial impact. ... "Employer Group and Individual Business Analytics ...
(Date:6/19/2013)... 2013  It may seem like an odd pairing: an ... But these were two of the most talked about topics ... Meeting & Expo that just convened in San ... by some of the top internal medicine experts in the ... research that can not only save lives, but help people ...
(Date:6/18/2013)... -- Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), a ... commercialization of novel bile acid therapeutics to treat chronic ... public offering of 1,730,000 shares of its common stock ... In addition, Intercept has granted the underwriters a 30-day ... of common stock. All of the shares ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... Cempra Pharmaceuticals, a developer of differentiated antibiotics, ... (IV) solithromycin demonstrates excellent tolerability and ... up to 800 mg.  Oral administration of solithromycin ... 1 studies.  The presentation will be at the ...
... Covance Inc. (NYSE: CVD ) today announced that ... Tuesday, May 10, 2011 at 3:00 p.m. ET.  Investors may ... .  In order to register and download any necessary software, ... headquarters in Princeton, New Jersey, is one of the world,s ...
Cached Medicine Technology:Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 3Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 4Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 5Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 6Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 7Covance to Present at Baird's 2011 Growth Stock Conference 2
... Sensor Intravascular Mikro-Tip Pressure Catheters; Millar ... dual pressure sensor catheters for simultaneous ... are suitable for measuring pressure gradients ... across a vascular stenosis. The catheters ...
... Dual Pressure Sensor Intravascular Mikro-Tip ... a line of dual pressure sensor ... measurements. These catheters are suitable for ... between chambers, or across a vascular ...
... TITAN, a high-resolution modular ultrasound solution. ... state of the art high-resolution imaging ... care. The TITAN system's modular design ... and mobile usage. , Point-of-care connectivity. ...
... The XTD Thrombectomy catheter is a ... remove thrombus from occluded hemodialysis access grafts. ... and consists of a rotatable, spiral shaft ... as a flexible, distal curved tip. In ...
Medicine Products: